HEADER IMMUNE SYSTEM 03-JUN-22 8A2J TITLE HUMAN STING IN COMPLEX WITH 2'-3'-CYCLIC-GMP-7-DEAZA(4-BIPHENYLYL)-AMP COMPND MOL_ID: 1; COMPND 2 MOLECULE: STIMULATOR OF INTERFERON GENES PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HSTING,ENDOPLASMIC RETICULUM INTERFERON STIMULATOR,ERIS, COMPND 5 MEDIATOR OF IRF3 ACTIVATION,HMITA,TRANSMEMBRANE PROTEIN 173; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STING1, ERIS, MITA, STING, TMEM173; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COMPLEX, STING, CYCLIC DINUCLEOTIDE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR Z.VAVRINA,J.BRYNDA,P.REZACOVA REVDAT 4 31-JAN-24 8A2J 1 REMARK REVDAT 3 09-NOV-22 8A2J 1 JRNL REVDAT 2 19-OCT-22 8A2J 1 JRNL REVDAT 1 12-OCT-22 8A2J 0 JRNL AUTH Z.VAVRINA,P.PERLIKOVA,N.MILISAVLJEVIC,F.CHEVRIER,M.SMOLA, JRNL AUTH 2 J.SMITH,M.DEJMEK,V.HAVLICEK,M.BUDESINSKY,R.LIBOSKA, JRNL AUTH 3 L.VANEKOVA,J.BRYNDA,E.BOURA,P.REZACOVA,M.HOCEK,G.BIRKUS JRNL TITL DESIGN, SYNTHESIS, AND BIOCHEMICAL AND BIOLOGICAL EVALUATION JRNL TITL 2 OF NOVEL 7-DEAZAPURINE CYCLIC DINUCLEOTIDE ANALOGUES AS JRNL TITL 3 STING RECEPTOR AGONISTS. JRNL REF J.MED.CHEM. V. 65 14082 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 36201304 JRNL DOI 10.1021/ACS.JMEDCHEM.2C01305 REMARK 2 REMARK 2 RESOLUTION. 2.32 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.32 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.02 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 17820 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 888 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.0200 - 4.2100 0.99 3002 153 0.2368 0.2358 REMARK 3 2 4.2100 - 3.3500 1.00 2847 156 0.2042 0.2545 REMARK 3 3 3.3500 - 2.9200 1.00 2818 146 0.2102 0.2517 REMARK 3 4 2.9200 - 2.6600 1.00 2795 151 0.2432 0.3197 REMARK 3 5 2.6600 - 2.4700 0.98 2748 141 0.2359 0.3225 REMARK 3 6 2.4700 - 2.3200 0.97 2722 141 0.2325 0.2969 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.810 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND ((RESID 153 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 154 THROUGH 179 OR (RESID 180 REMARK 3 THROUGH 181 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 182 THROUGH 184 OR (RESID 185 THROUGH 186 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 187 OR (RESID REMARK 3 193 THROUGH 194 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 195 THROUGH 212 OR RESID 214 THROUGH 237 REMARK 3 OR (RESID 238 THROUGH 239 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 240 THROUGH 282 OR (RESID 283 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 284 THROUGH 285 REMARK 3 OR (RESID 286 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 287 THROUGH 292 OR (RESID 293 AND (NAME N REMARK 3 OR NAME CA OR NAME C OR NAME O OR NAME CB REMARK 3 )) OR RESID 294 THROUGH 330 OR RESID 332 REMARK 3 THROUGH 334 OR (RESID 335 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 336)) REMARK 3 SELECTION : (CHAIN B AND (RESID 153 THROUGH 173 OR REMARK 3 (RESID 174 AND (NAME N OR NAME CA OR NAME REMARK 3 C OR NAME O OR NAME CB )) OR RESID 175 REMARK 3 THROUGH 195 OR (RESID 196 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 197 THROUGH 212 OR RESID 214 REMARK 3 THROUGH 251 OR (RESID 252 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 253 THROUGH 295 OR (RESID 296 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 297 THROUGH 300 REMARK 3 OR (RESID 301 THROUGH 302 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 303 THROUGH 319 OR (RESID 321 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 322 THROUGH 330 REMARK 3 OR RESID 332 THROUGH 336)) REMARK 3 ATOM PAIRS NUMBER : 1437 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8A2J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1292123143. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-OCT-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 200K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21423 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.320 REMARK 200 RESOLUTION RANGE LOW (A) : 36.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 5.417 REMARK 200 R MERGE (I) : 0.19300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.81 REMARK 200 R MERGE FOR SHELL (I) : 1.86900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.790 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: 4KSY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM CITRIC ACID, 20% (W/V) PEG REMARK 280 6000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 47.14500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.45500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 47.14500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.45500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 139 REMARK 465 ALA A 140 REMARK 465 PRO A 141 REMARK 465 ALA A 142 REMARK 465 GLU A 143 REMARK 465 ILE A 144 REMARK 465 SER A 145 REMARK 465 ALA A 146 REMARK 465 VAL A 147 REMARK 465 CYS A 148 REMARK 465 GLU A 149 REMARK 465 LYS A 150 REMARK 465 ALA A 318 REMARK 465 ASP A 319 REMARK 465 LYS A 338 REMARK 465 GLU A 339 REMARK 465 GLU A 340 REMARK 465 VAL A 341 REMARK 465 THR A 342 REMARK 465 VAL A 343 REMARK 465 GLY A 344 REMARK 465 SER A 345 REMARK 465 LEU A 346 REMARK 465 LYS A 347 REMARK 465 THR A 348 REMARK 465 SER A 349 REMARK 465 ALA A 350 REMARK 465 VAL A 351 REMARK 465 PRO A 352 REMARK 465 SER A 353 REMARK 465 THR A 354 REMARK 465 SER A 355 REMARK 465 THR A 356 REMARK 465 MET A 357 REMARK 465 SER A 358 REMARK 465 GLN A 359 REMARK 465 GLU A 360 REMARK 465 PRO A 361 REMARK 465 GLU A 362 REMARK 465 LEU A 363 REMARK 465 LEU A 364 REMARK 465 ILE A 365 REMARK 465 SER A 366 REMARK 465 GLY A 367 REMARK 465 MET A 368 REMARK 465 GLU A 369 REMARK 465 LYS A 370 REMARK 465 PRO A 371 REMARK 465 LEU A 372 REMARK 465 PRO A 373 REMARK 465 LEU A 374 REMARK 465 ARG A 375 REMARK 465 THR A 376 REMARK 465 ASP A 377 REMARK 465 PHE A 378 REMARK 465 SER A 379 REMARK 465 SER B 139 REMARK 465 ALA B 140 REMARK 465 PRO B 141 REMARK 465 ALA B 142 REMARK 465 GLU B 143 REMARK 465 ILE B 144 REMARK 465 SER B 145 REMARK 465 ALA B 146 REMARK 465 VAL B 147 REMARK 465 CYS B 148 REMARK 465 GLU B 149 REMARK 465 LYS B 150 REMARK 465 GLY B 151 REMARK 465 ASN B 152 REMARK 465 ASN B 188 REMARK 465 LEU B 189 REMARK 465 LEU B 190 REMARK 465 ARG B 191 REMARK 465 GLY B 192 REMARK 465 ALA B 318 REMARK 465 LYS B 338 REMARK 465 GLU B 339 REMARK 465 GLU B 340 REMARK 465 VAL B 341 REMARK 465 THR B 342 REMARK 465 VAL B 343 REMARK 465 GLY B 344 REMARK 465 SER B 345 REMARK 465 LEU B 346 REMARK 465 LYS B 347 REMARK 465 THR B 348 REMARK 465 SER B 349 REMARK 465 ALA B 350 REMARK 465 VAL B 351 REMARK 465 PRO B 352 REMARK 465 SER B 353 REMARK 465 THR B 354 REMARK 465 SER B 355 REMARK 465 THR B 356 REMARK 465 MET B 357 REMARK 465 SER B 358 REMARK 465 GLN B 359 REMARK 465 GLU B 360 REMARK 465 PRO B 361 REMARK 465 GLU B 362 REMARK 465 LEU B 363 REMARK 465 LEU B 364 REMARK 465 ILE B 365 REMARK 465 SER B 366 REMARK 465 GLY B 367 REMARK 465 MET B 368 REMARK 465 GLU B 369 REMARK 465 LYS B 370 REMARK 465 PRO B 371 REMARK 465 LEU B 372 REMARK 465 PRO B 373 REMARK 465 LEU B 374 REMARK 465 ARG B 375 REMARK 465 THR B 376 REMARK 465 ASP B 377 REMARK 465 PHE B 378 REMARK 465 SER B 379 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 174 CG CD OE1 OE2 REMARK 470 GLN A 196 CG CD OE1 NE2 REMARK 470 MET A 214 CG SD CE REMARK 470 LYS A 224 CG CD CE NZ REMARK 470 LYS A 236 CG CD CE NZ REMARK 470 ASP A 237 CG OD1 OD2 REMARK 470 VAL A 239 CG1 CG2 REMARK 470 GLN A 252 CG CD OE1 NE2 REMARK 470 ARG A 281 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 282 CG CD OE1 OE2 REMARK 470 GLU A 296 CG CD OE1 OE2 REMARK 470 ASP A 301 CG OD1 OD2 REMARK 470 GLN A 306 CG CD OE1 NE2 REMARK 470 ARG A 310 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 316 CG CD OE1 OE2 REMARK 470 ASP A 320 CG OD1 OD2 REMARK 470 SER A 321 OG REMARK 470 GLU A 337 CG CD OE1 OE2 REMARK 470 PHE B 153 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 180 CG CD NE CZ NH1 NH2 REMARK 470 THR B 181 OG1 CG2 REMARK 470 HIS B 185 CG ND1 CD2 CE1 NE2 REMARK 470 TYR B 186 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 VAL B 194 CG1 CG2 REMARK 470 MET B 214 CG SD CE REMARK 470 LYS B 224 CG CD CE NZ REMARK 470 LYS B 236 CG CD CE NZ REMARK 470 ASP B 237 CG OD1 OD2 REMARK 470 ARG B 238 CG CD NE CZ NH1 NH2 REMARK 470 VAL B 239 CG1 CG2 REMARK 470 ARG B 281 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 282 CG CD OE1 OE2 REMARK 470 ASP B 283 CG OD1 OD2 REMARK 470 GLU B 286 CG CD OE1 OE2 REMARK 470 ARG B 293 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 306 CG CD OE1 NE2 REMARK 470 ARG B 310 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 316 CG CD OE1 OE2 REMARK 470 ASP B 319 CG OD1 OD2 REMARK 470 ASP B 320 CG OD1 OD2 REMARK 470 ARG B 331 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 335 CG CD OE1 NE2 REMARK 470 GLU B 337 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR B 267 O HOH B 501 2.14 REMARK 500 OE1 GLN A 227 O HOH A 401 2.16 REMARK 500 OG SER B 241 O HOH B 502 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 167 -70.61 -144.70 REMARK 500 ASN A 188 41.51 -90.22 REMARK 500 LEU A 202 72.91 -119.62 REMARK 500 GLN A 306 65.23 -117.20 REMARK 500 TYR B 167 -73.52 -145.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8A2I RELATED DB: PDB REMARK 900 RELATED ID: 8A2K RELATED DB: PDB REMARK 900 RELATED ID: 8A2H RELATED DB: PDB DBREF 8A2J A 140 379 UNP Q86WV6 STING_HUMAN 140 379 DBREF 8A2J B 140 379 UNP Q86WV6 STING_HUMAN 140 379 SEQADV 8A2J SER A 139 UNP Q86WV6 EXPRESSION TAG SEQADV 8A2J ARG A 232 UNP Q86WV6 HIS 232 VARIANT SEQADV 8A2J SER B 139 UNP Q86WV6 EXPRESSION TAG SEQADV 8A2J ARG B 232 UNP Q86WV6 HIS 232 VARIANT SEQRES 1 A 241 SER ALA PRO ALA GLU ILE SER ALA VAL CYS GLU LYS GLY SEQRES 2 A 241 ASN PHE ASN VAL ALA HIS GLY LEU ALA TRP SER TYR TYR SEQRES 3 A 241 ILE GLY TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA SEQRES 4 A 241 ARG ILE ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU SEQRES 5 A 241 ARG GLY ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO SEQRES 6 A 241 LEU ASP CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP SEQRES 7 A 241 PRO ASN ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR SEQRES 8 A 241 GLY ASP ARG ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SEQRES 9 A 241 SER ILE TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY SEQRES 10 A 241 THR CYS VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU SEQRES 11 A 241 PHE ALA MET SER GLN TYR SER GLN ALA GLY PHE SER ARG SEQRES 12 A 241 GLU ASP ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR SEQRES 13 A 241 LEU GLU ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN SEQRES 14 A 241 ASN CYS ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SEQRES 15 A 241 SER SER PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU SEQRES 16 A 241 ARG GLN GLU GLU LYS GLU GLU VAL THR VAL GLY SER LEU SEQRES 17 A 241 LYS THR SER ALA VAL PRO SER THR SER THR MET SER GLN SEQRES 18 A 241 GLU PRO GLU LEU LEU ILE SER GLY MET GLU LYS PRO LEU SEQRES 19 A 241 PRO LEU ARG THR ASP PHE SER SEQRES 1 B 241 SER ALA PRO ALA GLU ILE SER ALA VAL CYS GLU LYS GLY SEQRES 2 B 241 ASN PHE ASN VAL ALA HIS GLY LEU ALA TRP SER TYR TYR SEQRES 3 B 241 ILE GLY TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA SEQRES 4 B 241 ARG ILE ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU SEQRES 5 B 241 ARG GLY ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO SEQRES 6 B 241 LEU ASP CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP SEQRES 7 B 241 PRO ASN ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR SEQRES 8 B 241 GLY ASP ARG ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SEQRES 9 B 241 SER ILE TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY SEQRES 10 B 241 THR CYS VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU SEQRES 11 B 241 PHE ALA MET SER GLN TYR SER GLN ALA GLY PHE SER ARG SEQRES 12 B 241 GLU ASP ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR SEQRES 13 B 241 LEU GLU ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN SEQRES 14 B 241 ASN CYS ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SEQRES 15 B 241 SER SER PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU SEQRES 16 B 241 ARG GLN GLU GLU LYS GLU GLU VAL THR VAL GLY SER LEU SEQRES 17 B 241 LYS THR SER ALA VAL PRO SER THR SER THR MET SER GLN SEQRES 18 B 241 GLU PRO GLU LEU LEU ILE SER GLY MET GLU LYS PRO LEU SEQRES 19 B 241 PRO LEU ARG THR ASP PHE SER HET KWO B 401 57 HETNAM KWO 2-AZANYL-9-[(1~{R},6~{R},8~{R},9~{R},10~{S},15~{R}, HETNAM 2 KWO 17~{R},18~{R})-8-[4-AZANYL-5-(4-PHENYLPHENYL) HETNAM 3 KWO PYRROLO[2,3-D]PYRIMIDIN-7-YL]-3,9,12,18- HETNAM 4 KWO TETRAKIS(OXIDANYL)-3,12-BIS(OXIDANYLIDENE)-2,4,7,11, HETNAM 5 KWO 13,16-HEXAOXA-3$L^{5},12$L^{5}- HETNAM 6 KWO DIPHOSPHATRICYCLO[13.2.1.0^{6,10}]OCTADECAN-17-YL]- HETNAM 7 KWO 1~{H}-PURIN-6-ONE HETSYN KWO 2-AZANYL-9-[(1~{R},6~{R},8~{R},9~{R},10~{S},15~{R}, HETSYN 2 KWO 17~{R},18~{R})-8-[4-AZANYL-5-(4-PHENYLPHENYL) HETSYN 3 KWO PYRROLO[2,3-D]PYRIMIDIN-7-YL]-3,9,12,18- HETSYN 4 KWO TETRAKIS(OXIDANYL)-3,12-BIS(OXIDANYLIDENE)-2,4,7,11, HETSYN 5 KWO 13,16-HEXAOXA-3$L^{5},12$L^{5}- HETSYN 6 KWO DIPHOSPHATRICYCLO[13.2.1.0^{6,10}]OCTADECAN-17-YL]- HETSYN 7 KWO 1~{H}-PURIN-6-ONE FORMUL 3 KWO C33 H33 N9 O13 P2 FORMUL 4 HOH *92(H2 O) HELIX 1 AA1 GLY A 151 GLY A 166 1 16 HELIX 2 AA2 TYR A 167 ASN A 187 1 21 HELIX 3 AA3 THR A 263 TYR A 274 1 12 HELIX 4 AA4 SER A 275 GLY A 278 5 4 HELIX 5 AA5 SER A 280 ASP A 301 1 22 HELIX 6 AA6 SER A 324 GLU A 336 1 13 HELIX 7 AA7 ASN B 154 TYR B 167 1 14 HELIX 8 AA8 TYR B 167 LEU B 172 1 6 HELIX 9 AA9 GLU B 174 ASN B 183 1 10 HELIX 10 AB1 ASN B 211 ASP B 216 1 6 HELIX 11 AB2 THR B 263 SER B 272 1 10 HELIX 12 AB3 TYR B 274 GLY B 278 5 5 HELIX 13 AB4 SER B 280 ALA B 300 1 21 HELIX 14 AB5 ALA B 302 ASN B 307 1 6 HELIX 15 AB6 SER B 324 GLU B 337 1 14 SHEET 1 AA1 5 ILE A 219 LYS A 224 0 SHEET 2 AA1 5 SER A 243 GLU A 249 -1 O ILE A 244 N ASP A 223 SHEET 3 AA1 5 GLN A 252 TYR A 261 -1 O GLN A 252 N GLU A 249 SHEET 4 AA1 5 LEU A 198 PRO A 203 1 N TYR A 199 O VAL A 258 SHEET 5 AA1 5 CYS A 309 TYR A 314 1 O ILE A 312 N LEU A 202 SHEET 1 AA2 2 GLN A 228 ARG A 232 0 SHEET 2 AA2 2 ILE A 235 TYR A 240 -1 O TYR A 240 N GLN A 228 SHEET 1 AA3 5 ILE B 219 LYS B 224 0 SHEET 2 AA3 5 SER B 243 GLU B 249 -1 O ILE B 244 N ASP B 223 SHEET 3 AA3 5 GLN B 252 TYR B 261 -1 O ALA B 254 N LEU B 247 SHEET 4 AA3 5 LEU B 198 PRO B 203 1 N TYR B 199 O VAL B 258 SHEET 5 AA3 5 CYS B 309 TYR B 314 1 O ILE B 312 N LEU B 202 SHEET 1 AA4 2 GLN B 228 ARG B 232 0 SHEET 2 AA4 2 ILE B 235 TYR B 240 -1 O TYR B 240 N GLN B 228 CRYST1 94.290 116.910 35.980 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010606 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008554 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027793 0.00000